Yamout BI - Search Results

1

Functional clinical outcomes in multiple sclerosis: Current status and future prospects.

Karabudak R, Dahdaleh M, Aljumah M, Alroughani R, Alsharoqi IA, AlTahan AM, Bohlega SA, Daif A, Deleu D, Amous A, Inshasi JS, Rieckmann P, Sahraian MA, Yamout BI. Karabudak R, et al. Among authors: yamout bi. Mult Scler Relat Disord. 2015 May;4(3):192-201. doi: 10.1016/j.msard.2015.03.004. Epub 2015 Mar 23. Mult Scler Relat Disord. 2015. PMID: 26008936 Review.

2

Clinical characteristics of multiple sclerosis in Lebanon.

Yamout B, Barada W, Tohme RA, Mehio-Sibai A, Khalifeh R, El-Hajj T. Yamout B, et al. J Neurol Sci. 2008 Jul 15;270(1-2):88-93. doi: 10.1016/j.jns.2008.02.009. Epub 2008 Mar 25. J Neurol Sci. 2008. PMID: 18367208

3

Biosimilars: opinion of an expert panel in the Middle East.

Bohlega S, Al-Shammri S, Al Sharoqi I, Dahdaleh M, Gebeily S, Inshasi J, Khalifa A, Pakdaman H, Szólics M, Yamout B. Bohlega S, et al. Curr Med Res Opin. 2008 Oct;24(10):2897-903. doi: 10.1185/03007990802381554. Epub 2008 Sep 2. Curr Med Res Opin. 2008. PMID: 18768104 Review.

4

Vocal symptoms and acoustic changes in relation to the expanded disability status scale, duration and stage of disease in patients with multiple sclerosis.

Yamout B, Fuleihan N, Hajj T, Sibai A, Sabra O, Rifai H, Hamdan AL. Yamout B, et al. Eur Arch Otorhinolaryngol. 2009 Nov;266(11):1759-65. doi: 10.1007/s00405-009-1003-y. Epub 2009 Jun 10. Eur Arch Otorhinolaryngol. 2009. PMID: 19513739

5

Celiac disease, Behçet, and idiopathic thrombocytopenic purpura in siblings of a patient with multiple sclerosis.

Yamout B, Usta J, Itani S, Yaghi S. Yamout B, et al. Mult Scler. 2009 Nov;15(11):1368-71. doi: 10.1177/1352458509345908. Epub 2009 Oct 13. Mult Scler. 2009. PMID: 19825890

6

A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.

Giovannoni G, Comi G, Cook S, Rammohan K, Rieckmann P, Soelberg Sørensen P, Vermersch P, Chang P, Hamlett A, Musch B, Greenberg SJ; CLARITY Study Group. Giovannoni G, et al. N Engl J Med. 2010 Feb 4;362(5):416-26. doi: 10.1056/NEJMoa0902533. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089960 Free article. Clinical Trial.

7

Adherence to disease-modifying drugs in patients with multiple sclerosis: a consensus statement from the Middle East MS Advisory Group.

Yamout BI, Dahdaleh M, Al Jumah MA, Al-Shammri S, Al Sharoqi I, Al-Tahan AR, Bohlega S, Deleu D, Inshasi J, Khalifa A, Szólics M. Yamout BI, et al. Int J Neurosci. 2010 Apr;120(4):273-9. doi: 10.3109/00207450903541087. Int J Neurosci. 2010. PMID: 20374075

8

Prognostic factors of multiple sclerosis in Lebanon.

Yamout B, Itani S, Arabi A, Hamzeh D, Yaghi S. Yamout B, et al. Int J Neurosci. 2010 Mar;120(3):206-10. doi: 10.3109/00207450903464587. Int J Neurosci. 2010. PMID: 20374088

9

Extracranial venous stenosis is an unlikely cause of multiple sclerosis.

Yamout B, Herlopian A, Issa Z, Habib RH, Fawaz A, Salame J, Wadih A, Awdeh H, Muallem N, Raad R, Al-Kutoubi A. Yamout B, et al. Mult Scler. 2010 Nov;16(11):1341-8. doi: 10.1177/1352458510385268. Mult Scler. 2010. PMID: 21041329

10

Will new injection devices for interferon β-1a s.c. affect treatment adherence in patients with multiple sclerosis? An expert opinion in the Middle East.

Deleu D, Alsharoqi I, Al Jumah MA, Al Tahan AR, Bohlega S, Dahdaleh M, Inshasi J, Khalifa A, Szólics M, Yamout BI. Deleu D, et al. Among authors: yamout bi. Int J Neurosci. 2011 Apr;121(4):171-5. doi: 10.3109/00207454.2010.541572. Int J Neurosci. 2011. PMID: 21329472 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters